USA

Progressivists Express Concerns About Reducing Potential US Settlement Bills – Live | US News




Biden attends US-ASEAN summit skipped by Trump







The Food and Drug Administration Advisory Board will only discuss the Pfizer-BioNTech vaccine. The suggested dose for children is 10 micrograms, or one-third of the adult dose of the Pfizer-BioNTech vaccine.

Moderna released on Monday Promising early results For vaccines in children aged 6 to 11, the trial is still underway.

Looking at all the scientific evidence, the advisor recommends this low-dose Pfizer-BioNTech vaccine to the FDA. The FDA does not have to follow the advisor’s recommendations, but the FDA usually does.

If an adviser to the US Centers for Disease Control and Prevention (CDC) also recommends a vaccine at next week’s meeting, Deploy immediately It shows significant progress in the United States’ response to the coronavirus to children over the age of five across the country.

Almost 118,000 children were Covid-positive last week, and a total of more than 1 million children have been newly infected in the last six weeks. according to To the American Pediatric Society. At least 584 US children have died in Covid.

In addition to protecting your child from Covid-19 and its long-term effects, vaccination also helps protect the children around you.

“We cannot get out of this pandemic without vaccination of our children, both for ourselves and for our overall protection,” said an infectious disease epidemiologist. Dr. Saad Omer, director of the Yale University Institute for Global Health, said. Said Guardian earlier this month.




FDA Weighs Coronavirus Vaccine for Children 5-11 Years

Today, US Food and Drug Administration (FDA) advisors are considering applying the Pfizer-BioNTech Covid-19 vaccine for children ages 5-11.

If approved, it will be the first vaccine available to younger children in the United States.

The advisory board discusses the effectiveness of the vaccine and the potential risk of side effects such as myocarditis (a type of heart inflammation) before making recommendations to regulatory agencies at the end of the day.

Data from Pfizer-BioNTech released on Friday shows vaccines 90.7% valid For prevention of symptomatic treatment in this age group.

The benefits of vaccination “clearly outweigh the risks of myocarditis and pericarditis,” FDA scientists conclude. analysis It was also released on Friday.




Progressive raises concerns about a potential settlement agreement with Manchin



Progressivists Express Concerns About Reducing Potential US Settlement Bills – Live | US News

Source link Progressivists Express Concerns About Reducing Potential US Settlement Bills – Live | US News

Back to top button